CHRONIC PROGRESSIVE PARANEOPLASTIC SYNDROME WITH PROMINENT BRAINSTEM AND SPINAL CORD INVOLVEMENT, ASSOCIATED WITH TYPE-2 ANTI-NEURONAL NUCLEAR ANTIBODIES (ANNA-2) AND BREAST CARCINOMA

1995 ◽  
Vol 54 (3) ◽  
pp. 464 ◽  
Author(s):  
S. F. Hunter ◽  
J. E. Parisi ◽  
S. L. Mastovich ◽  
W. Power ◽  
B. Delahoussaye ◽  
...  
2010 ◽  
Vol 258 (5) ◽  
pp. 921-922 ◽  
Author(s):  
Domenico Plantone ◽  
Pietro Caliandro ◽  
Raffaele Iorio ◽  
Giovanni Frisullo ◽  
Viviana Nociti ◽  
...  

2019 ◽  
Author(s):  
Ines El Naggar ◽  
Eva-Maria Wendel ◽  
Christian Lechner ◽  
Kathrin Schanda ◽  
Michael Karenfort ◽  
...  

Author(s):  
Davide Tonduti ◽  
Eleonora Mura ◽  
Silvia Masnada ◽  
Enrico Bertini ◽  
Chiara Aiello ◽  
...  

2018 ◽  
Vol 16 (2) ◽  
pp. 274-274
Author(s):  
Simone E Dekker ◽  
Chad A Glenn ◽  
Thomas A Ostergard ◽  
Osmond C Wu ◽  
Fernando Alonso ◽  
...  

Abstract This 3-dimensional operative video illustrates resection of 2 cervical spine schwannomas in a 19-yr-old female with neurofibromatosis type 2. The patient presented with lower extremity hyperreflexity and hypertonicity. Magnetic resonance imaging (MRI) demonstrated 2 contrast-enhancing intradural extramedullary cervical spine lesions causing spinal cord compression at C4 and C5. The patient underwent a posterior cervical laminoplasty with a midline dural opening for tumor resection. Curvilinear spine cord compression is demonstrated in the operative video. After meticulous dissection, the tumors were resected without complication. The dural closure was performed in watertight fashion followed by laminoplasty using osteoplastic titanium miniplates and screws. Postoperative MRI demonstrated gross total resection with excellent decompression of the spinal cord. The postoperative course was uneventful. The natural history of this disease, treatment options, and potential complications are discussed.


2014 ◽  
Vol 6 (2) ◽  
pp. 227-229 ◽  
Author(s):  
Roshija Khanal Rijal ◽  
Dr Chinmay Nakhwa ◽  
Manavi D Sindal D Manavi D Sindal

Introduction: Tamoxifen citrate is an anti-estrogen agent used in the treatment of breast carcinoma. Crystalline maculopathy is a rare complication of tamoxifen therapy. The clinical picture resembles that of idiopathic macular telangiectasia (IMT) Type 2, which is a more common clinical entity.  Objective: To report a case of crystalline maculopathy secondary to tamoxifen and highlight the importance of the medical history and investigations in differentiating it from IMT Type 2.  Case: A diabetic female with a past history of breast carcinoma treated with tamoxifen came to the hospital for a routine eye check-up. Crystalline deposits were seen in the parafoveal region in both the eyes. The spectral domain optical coherence tomography (SD-OCT) showed foveal cysts in the inner retinal layer and fundus autofluorescence (FAF) and fundus fluorescein angiography (FFA) were within normal limits.  Conclusion: While tamoxifen maculopathy is reversible on stopping the therapy, IMT needs a long-term follow-up to monitor the potential risk of loss of vision due to choroidal neovascularization, hence necessitating the distinction between these two different clinical entities.DOI: http://dx.doi.org/10.3126/nepjoph.v6i2.11713Nepal J Ophthalmol 2014; 6 (12): 227-229 


Sign in / Sign up

Export Citation Format

Share Document